Tag: NovaBay Pharmaceuticals Inc.

A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The metric has seen a significant loss of -60.05% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -78.46%. Over the past 30 days, the price of NBY has leaped by -39.50%. And in the last five days, it has fallen by -11.51%. The market performance of Novabay Pharmaceuticals Inc’s stock has been turbulent in recent times. Over the last

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Novabay Pharmaceuticals Inc’s current trading price is -93.22% away from its 52-week high, while its distance from the 52-week low is 7.52%. The stock’s price range for this period has been between $0.12 and $1.95 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 10.67 million for the day, a number notably higher than the average daily volume of 3.08 million over the last three months. Novabay Pharmaceuticals Inc experienced a somewhat shaky